CKD increases the risk of hospital-acquired acute renal failure (ARF), a study shows. The greater the degree of underlying renal impairment, the greater the ARF risk.

Parenteral estrogen therapy with high-dose polyestradiol phosphate (PEP, Estradurin) has anticancer efficacy similar to that of combined androgen deprivation (CAD) in patients with metastatic prostate cancer, researchers report.

Evaluating how predialysis patients rise from a chair may provide a simple way to identify those who need help with muscle training and functional exercise, according to researchers in Sweden and Norway.

Six months of mycophenolate mofetil (MMF) treatment is as effective in the short term as conventional therapy for primary treatment of membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS), a pilot study in India found.

Patient weight changes after renal transplantation may be a marker for poor survival, data suggest.

DESPITE INTENSIVE dietary intervention, malnutrition remains prevalent in stage 5 CKD, affecting 20%-70% of all patients. Malnutrition, as evidenced by hypoalbuminemia, is strongly associated with increased morbidity and mortality in this patient population.

Percutaneous nephrolithotomy (PCNL) improves the estimated glomerular filtration rate (eGFR) in patients with stage 5 CKD, but unexpected deterioration in renal function could occur in patients with earlier CKD stages, investigators in Turkey report.

Focal therapy with high-intensity focused ultrasound (HIFU) of localized prostate cancer provides immediate cancer control, comparable to that of other treatment modalities, according to Japanese researchers.

Antihypertensive treatment with perindopril prevents recurrent stroke in CKD patients across a wide spectrum of BP levels, according to Australian and Japanese researchers. They saw no evidence for a higher risk of stroke among individuals with low BP.

IMPAIRED BONE mineral metabolism is prevalent in CKD patients, presenting a special challenge for patients and renal health professionals. By stage 5 CKD, an estimated 50% or more of dialysis patients have bone mineral parameters that exceed evidence-based practice guidelines.